The ideal candidate for this post would have a hunger to break news and illuminate an often opaque and insular business and scientific community to the wider world. We’re looking for a reporter with a demonstrated capacity for writing clearly and authoritatively about complex science and medicine, a track record of scoops, and sources in the biotech, venture-capital and academic worlds. Biotechnology is more important than ever in a world that has been reshaped by a pandemic, and this role will require a reporter who is comfortable with collaborating across our newsroom on stories that answer big questions about health care, defense and preparedness, finance and macroeconomics.
This reporter will also track the movement of public and private money into promising companies, and unravel what happened when those bets go wrong. Knowledge of markets, investing and the financial world will be important to this reporter’s success.
To apply, go here.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…